Logo

Pfizer Licenses Jubilant s ChemBioBase Inhibitor Databases

Mar 01, 2005

NEW YORK, March 1 (GenomeWeb News) - Pfizer has taken a global license to Jubilant Biosys' ChemBioBase gene family-specific small molecule inhibitor databases, Bangalore, India-based Jubilant said recently.

 

The databases contain published inhibitors to the kinase, GPCR, protease, ion channel, and nuclear receptor classes of targets and includes structural and functional, disease, PK/PD, and other family-specific information.

 

Financial details of the licensing agreement were not disclosed.

Breaking News
The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.